A

Atreca, Inc.

101 employees

Atreca develops a technology to identify the set of antibodies produced during an immune response, without prior knowledge of an antigen.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Product Research
Therapeutics

Date founded

2011

Funding rounds raised

Total raised

$125M

from 12 investors over 12 rounds

A

Atreca, Inc. raised $125M on September 12, 2018

Investors: Aisling Capital, Samsara BioCapital, Tavistock Group, Tekla Capital Management, Redmile Group and Wellington Management

A

Atreca, Inc. raised $35M on August 17, 2017

Investors: Wellington Management and Mission BioCapital

A

Atreca, Inc. raised $56M on November 4, 2015

Investors: Mission Bay Capital, Evolution VC Partners and Bill & Melinda Gates Foundation

A

Atreca, Inc. raised $6M on September 25, 2012

Investors: Bill & Melinda Gates Foundation

FAQ